Clinical study for validation of safety and efficacy of Laooq Sapistan for symptomatic relief in Nazla (Common Cold)
Abstract
Nazla, also known as acute viral rhinopharyngitis, nasopharyngitis, common cold, acute coryza, or just cold, is a viral infection of the upper respiratory tract that mostly affects the voice box, sinuses, throat, and nose. It is primarily caused by rhinoviruses and coronaviruses. The literature of Unani medicine describes Nazla-o-Zukām as a catarrhal fluid that flows from the anterior ventricles of the brain towards the throat and nose. A clinical study was conducted from 2016 to 2018 at the Central Research Institute of Unani Medicine (CRIUM), Basaha, Lucknow, to scientifically establish the safety and efficacy of the Unani pharmacopoeial formulation
How this paper connects to the literature. Drag to explore, click any node to open that paper.
